Pat Stiff

713 total citations
13 papers, 208 citations indexed

About

Pat Stiff is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Pat Stiff has authored 13 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Genetics and 5 papers in Hematology. Recurrent topics in Pat Stiff's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (2 papers). Pat Stiff is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (2 papers). Pat Stiff collaborates with scholars based in United States, Hungary and Spain. Pat Stiff's co-authors include R.A. Brown, Jack W. Singer, C Wheeler, Christos Emmanouilides, Carl E. Freter, CF LeMaistre, R. Gingrich, Selina M. Luger, Alan F. List and Mala Parthasarathy and has published in prestigious journals such as Journal of Clinical Oncology, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.

In The Last Decade

Pat Stiff

13 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pat Stiff United States	7	90	89	73	68	38	13	208
R.B. Berryman United States	8	92 1.0×	104 1.2×	111 1.5×	40 0.6×	50 1.3×	16	237
G Perea Spain	6	89 1.0×	104 1.2×	138 1.9×	57 0.8×	32 0.8×	7	228
Daniela Pietrasanta Italy	7	102 1.1×	78 0.9×	121 1.7×	60 0.9×	39 1.0×	19	244
Aline Clavert France	10	125 1.4×	55 0.6×	54 0.7×	86 1.3×	33 0.9×	23	225
Alessandra Cuttica Italy	8	87 1.0×	147 1.7×	204 2.8×	80 1.2×	47 1.2×	10	287
Masahiro Sekimizu Japan	8	42 0.5×	89 1.0×	131 1.8×	23 0.3×	44 1.2×	42	249
Olga Grishina Germany	7	161 1.8×	46 0.5×	46 0.6×	60 0.9×	41 1.1×	16	269
E. Alyea United States	8	192 2.1×	71 0.8×	77 1.1×	102 1.5×	47 1.2×	14	300
Silja Mack Germany	4	158 1.8×	63 0.7×	52 0.7×	89 1.3×	12 0.3×	6	265
Jennifer Massey Australia	9	69 0.8×	94 1.1×	173 2.4×	22 0.3×	65 1.7×	23	282

Countries citing papers authored by Pat Stiff

Since Specialization

Citations

This map shows the geographic impact of Pat Stiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Stiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Stiff more than expected).

Fields of papers citing papers by Pat Stiff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pat Stiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Stiff. The network helps show where Pat Stiff may publish in the future.

Co-authorship network of co-authors of Pat Stiff

This figure shows the co-authorship network connecting the top 25 collaborators of Pat Stiff. A scholar is included among the top collaborators of Pat Stiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pat Stiff. Pat Stiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Prockop, Susan E., Amer Beitinjaneh, Sylvain Choquet, et al.. (2022). S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE). HemaSphere. 6. 157–158. 2 indexed citations

Sweetenham, John, Jan Walewski, Tamás Masszi, et al.. (2016). Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse. Biology of Blood and Marrow Transplantation. 22(3). S36–S37. 12 indexed citations

Mumby, Patricia, et al.. (2011). Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplantation. 47(4). 556–561. 16 indexed citations

Stiff, Pat, Joseph M. Unger, James R. Cook, et al.. (2011). Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 29(15_suppl). 8001–8001. 37 indexed citations

Mumby, Patricia, C. Bousoño García, Karen Rychlik, et al.. (2010). The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant (BMT).. Journal of Clinical Oncology. 28(15_suppl). 9132–9132. 1 indexed citations

Fanale, Michelle A., et al.. (2009). 9209 Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study. European Journal of Cancer Supplements. 7(2). 563–563. 8 indexed citations

Gardner, Sharon L., Joaquim Carreras, C. Elizabeth Boudreau, et al.. (2008). Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplantation. 41(10). 867–872. 22 indexed citations

Odenike, Olatoyosi, John E. Godwin, Koen van Besien, et al.. (2007). Phase II trial of decitabine in myelofibrosis with myeloid metaplasia. Journal of Clinical Oncology. 25(18_suppl). 7088–7088. 3 indexed citations

Smith, Scott E., et al.. (2007). Gallium, rituximab, and dexamethasone for relapsed NHL. Journal of Clinical Oncology. 25(18_suppl). 8079–8079. 4 indexed citations

10.

Mumby, Patricia, et al.. (2004). Psychosocial predictors of autologous bone marrow transplant patients’ functioning: indications for early intervention. Biology of Blood and Marrow Transplantation. 10. 69–69. 1 indexed citations

11.

Stiff, Pat, C.F. LeMaistre, Robert Bayer, et al.. (2001). A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplantation. 28(3). 295–303. 25 indexed citations

12.

Stiff, Pat, R. Gingrich, Selina M. Luger, et al.. (2000). A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplantation. 26(5). 471–481. 72 indexed citations

13.

Stiff, Pat, et al.. (1995). High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.. PubMed. 1(12). 1495–502. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact